N-ACETYLATION POLYMORPHISM OF DAPSONE IN A JAPANESE POPULATION

被引：28

作者：

HORAI, Y ^{[1
]}

ISHIZAKI, T ^{[1
]}

机构：

[1] NATL MED CTR,CLIN RES INST,DIV CLIN PHARMACOL,TOYAMA 1-21-2,SHINJUKU KU,TOKYO,JAPAN

来源：

关键词：

D O I：

10.1111/j.1365-2125.1988.tb03333.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：487 / 494

页数：8

共 30 条

[1] PLASMA AND SALIVARY PHARMACOKINETICS OF DAPSONE ESTIMATED BY A THIN-LAYER CHROMATOGRAPHIC METHOD
AHMAD, RA
ROGERS, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 129 - 133
[2] CARR K, 1978, BRIT J CLIN PHARMACO, V6, P421, DOI 10.1111/j.1365-2125.1978.tb04606.x
[3] CARTWRIGHT RA, 1982, LANCET, V2, P842
[4] KINETIC DISCRIMINATION OF 3 SULFAMETHAZINE ACETYLATION PHENOTYPES
CHAPRON, DJ
KRAMER, PA
MERCIK, SA
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (01) : 104 - 113
[5] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS
CLARK, DWJ
[J]. DRUGS, 1985, 29 (04) : 342 - 375
[6] DRAYER DE, 1977, CLIN PHARMACOL THER, V22, P251
[7] SURVEY OF THE HUMAN ACETYLATOR POLYMORPHISM IN SPONTANEOUS DISORDERS
EVANS, DAP
[J]. JOURNAL OF MEDICAL GENETICS, 1984, 21 (04) : 243 - 253
[8] EVANS DAP, 1960, BRIT MED J, V2, P458
[9] EVANS DAP, 1986, ETHNIC DIFFERENCES R, P209
[10] GELBER R, 1971, CLIN PHARMACOL THER, V12, P225